Ratings Nomura Research Institute, Ltd. Deutsche Boerse AG

Equities

NR7

JP3762800005

Market Closed - Deutsche Boerse AG Other stock markets 02:30:03 2024-07-02 EDT			5-day change	1st Jan Change
26.2 ^EUR	+0.77%		+3.15%	+0.77%

07-02	Tranche Update on Nomura Research Institute, Ltd.'s Equity Buyback Plan announced on April 25, 2024.	CI
04-25	Nomura Research Institute’s Attributable Profit Up 4.8% in Fiscal 2024	MT

Strengths

Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 29.6 times its estimated earnings per share for the ongoing year.
With an enterprise value anticipated at 3.55 times the sales for the current fiscal year, the company turns out to be overvalued.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The company is highly valued given the cash flows generated by its activity.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: IT Services & Consulting

	1st Jan change	Capi.	ESG Refinitiv
NOMURA RESEARCH INSTITUTE, LTD.	+0.77%	16.18B	-
ACCENTURE PLC	-13.42%	190B	A-
TATA CONSULTANCY SERVICES LTD.	+5.90%	172B	B+
IBM	+8.41%	161B	B-
AUTOMATIC DATA PROCESSING, INC.	+1.57%	96.46B	A-
CROWDSTRIKE HOLDINGS, INC.	+50.81%	95.43B	C-
RELX PLC	+14.95%	84.2B	A-
INFOSYS LIMITED	+5.07%	78.93B	A
SNOWFLAKE INC.	-28.68%	47.81B	C
HCL TECHNOLOGIES LIMITED	+1.00%	47.66B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes